تجري حاليًا ترجمة هذا المقال. نعرض مؤقتًا النسخة الأصلية باللغة الإنجليزية.
التنظيم والقانون · 26/9/20161 دقائق للقراءة
Prospective Grant of Exclusive Patent License: Development of Adeno-Associated Virus-Based Vectors for the Treatment of Menkes Disease and Related Copper Transport Disorders
ترجمة آلية محلية · اللغة الأصلية للمصدر
الملخص
The Eunice Kennedy Shriver National Institute of Child Health and Human Development, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Commercialization Patent License to practice the inventions embodied in the U.S. Patents and Patent Applications listed in the Supplementary Information section of this notice to Cyprium Therapeutics, Inc. ("Cyprium") located in New York, NY, USA.
اللغة الأصلية للمصدر: Federal Register — All Documentsافتح البيان الأصلي →